Matinas BioPharma Holdings (MTNB) Other Accumulated Expenses (2016 - 2026)
Matinas BioPharma Holdings (MTNB) recorded Other Accumulated Expenses of $120,000 in Q3 2025, down 75.1% from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Other Accumulated Expenses (2016 - 2026) Analysis & Trends
At the end of FY2024, Matinas BioPharma Holdings reported Other Accumulated Expenses of $1.51 million.
- Annual Other Accumulated Expenses has a five-year compound annual growth rate of 930.3% (FY2019 to FY2024).
- Across earlier years, Other Accumulated Expenses came in at $88,000 in FY2022 (-90.2%), $899,000 in FY2021 (+39.8%) and $643,000 in FY2020.
- The Q3 2025 figure is the lowest quarterly Other Accumulated Expenses since Q4 2022.
- Per Business Quant, the preceding three quarters came in at $482,000 (Q2 2025), $922,000 (Q1 2025) and $1.51 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Matinas BioPharma Holdings | 508,224.03 | -12.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 718,000.00 |
| Dec 31, 2025 | 694,000.00 |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 482,000.00 |
| Mar 31, 2025 | 922,000.00 |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 733,000.00 |
| Jun 30, 2024 | 707,000.00 |
| Mar 31, 2024 | 681,000.00 |
| Dec 31, 2023 | 656,000.00 |
| Sep 30, 2023 | 632,000.00 |
| Jun 30, 2023 | 608,000.00 |
| Mar 31, 2023 | 585,000.00 |
| Dec 31, 2022 | 88,000.00 |
| Sep 30, 2022 | 194,000.00 |
| Jun 30, 2022 | 444,000.00 |
| Mar 31, 2022 | 702,000.00 |
| Dec 31, 2021 | 899,000.00 |
| Sep 30, 2021 | 1.23 Mn |
| Jun 30, 2021 | 840,000.00 |
API Access
Matinas BioPharma Holdings Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();